Study ID	Review's primary and secondary outcomes	Timing of outcome measurement in study
Chlup 2009	Resolution of symptoms	—
	Time to resolution of symptoms	—
	Blood or plasma glucose concentration at 20 minutes	Plasma glucose levels measured at 0, 5, 10, 15, 20 and 30 minutes
	Resolution of hypoglycaemia	—
	Time to resolution of hypoglycaemia	—
	Adverse events	—
	Treatment delay	—
Barennes 2005	Resolution of symptoms.	—
	Time to resolution of symptoms	—
	Blood or plasma glucose concentration at 20 minutes	Blood glucose levels measured at 0, 20, 40, 60 and 80 minutes
	Resolution of hypoglycaemia	At 80 minutes
	Time to resolution of hypoglycaemia	At 20 minutes
	Adverse events	At any time during study period (80 minutes)
	Treatment delay	—
Slama 1990	Resolution of symptoms	≤ 10, ≤ 15, ≤ 20 or > 20 minutes
	Time to resolution of symptoms	—
	Blood or plasma glucose concentration at 20 minutes	Plasma glucose was measured every minute for 10 minutes, and at 15 and 20 minutes
	Resolution of hypoglycaemia	—
	Time to resolution of hypoglycaemia	—
	Adverse events	—
	Treatment delay	—
Gunning 1978	Resolution of symptoms	—
	Time to resolution of symptoms	—
	Blood or plasma glucose concentration at 20 minutes	At 20 minutes
	Resolution of hypoglycaemia	—
	Time to resolution of hypoglycaemia	—
	Adverse events	—
	Treatment delay	—
— denotes not reported